Axxam installed a new technology platform for performing robotic high throughput screening (HTS) and ultra high-throughput screening (uHTS) of chemical libraries. Axxam implemented the most advanced instrumentation (CyBiTM-Cellight (CyBio AG) and FLIPRtetraTM (Molecular Devices Corporation Inc.) in a highly integrated and centralized structure, capable of performing screening campaigns which can generate over a million test points per day.
The new instrumentation operates with 384-well and 1536-well microtitre plates (MTPs) and provides a technologically advanced automated screening station integrating downstream existing platforms of bioinformatics, target biology and cellular and biochemical screening assay development.
